Louise Hiller Selected Research

Platinum

9/2009

Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Louise Hiller Research Topics

Disease

20	Breast Neoplasms (Breast Cancer) 01/2022 - 11/2006
7	Neoplasms (Cancer) 01/2022 - 04/2003
5	Cardiotoxicity 01/2020 - 12/2016
3	Neutropenia 01/2017 - 12/2015
2	Residual Neoplasm 01/2022 - 01/2017
2	Carcinoma (Carcinomatosis) 07/2007 - 04/2002
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2004 - 04/2002
1	Spontaneous Abortion (Miscarriage) 01/2023
1	Habitual Abortion (Recurrent Miscarriage) 01/2023
1	Thrombophilia 01/2023
1	Vomiting 01/2017
1	Myalgia 01/2017
1	Fatigue 01/2017
1	Infections 01/2017
1	Nausea 01/2017
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Arthralgia (Joint Pain) 01/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2016
1	Coronary Disease (Coronary Heart Disease) 01/2016
1	Genetic Risk Score 01/2016
1	Obesity 12/2015
1	Carcinogenesis 08/2010
1	Ovarian Neoplasms (Ovarian Cancer) 09/2009
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2008
1	Hypoxia (Hypoxemia) 05/2004
1	Transitional Cell Carcinoma 05/2004
1	Head and Neck Neoplasms (Head and Neck Cancer) 04/2003

Drug/Important Bio-Agent (IBA)

6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017 - 11/2006
5	Trastuzumab (Herceptin)FDA Link 01/2020 - 12/2016
5	AnthracyclinesIBA 01/2017 - 11/2006
5	Epirubicin (Ellence)FDA LinkGeneric 01/2017 - 11/2006
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 09/2009
4	Fluorouracil (Carac)FDA LinkGeneric 06/2015 - 11/2006
3	taxaneIBA 01/2017 - 05/2014
3	Methotrexate (Mexate)FDA LinkGeneric 09/2013 - 11/2006
3	Proteins (Proteins, Gene)FDA Link 11/2008 - 04/2002
2	Hormones (Hormone)IBA 01/2022 - 01/2017
2	Estrogen ReceptorsIBA 12/2017 - 11/2006
2	Gemcitabine FDA Link 01/2017 - 02/2014
2	Genetic Markers (Genetic Marker)IBA 01/2016 - 05/2015
2	Cisplatin (Platino)FDA LinkGeneric 09/2009 - 04/2003
2	Arginine (L-Arginine)FDA Link 09/2009 - 04/2003
1	Heparin (Liquaemin)FDA LinkGeneric 01/2023
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2023
1	AnticoagulantsIBA 01/2023
1	human ERBB2 proteinIBA 01/2020
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	Investigational DrugsIBA 09/2015
1	Bevacizumab (Avastin)FDA Link 06/2015
1	Docetaxel (Taxotere)FDA Link 06/2015
1	Taxoids (Taxanes)IBA 02/2014
1	1- (ethoxycarbonyloxymethyl)- 5- fluorouracilIBA 09/2013
1	CarcinogensIBA 08/2010
1	Biomarkers (Surrogate Marker)IBA 08/2010
1	CytokinesIBA 08/2010
1	Transforming Growth Factor beta (TGF-beta)IBA 08/2010
1	Carboplatin (JM8)FDA LinkGeneric 09/2009
1	Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA 09/2009
1	EnzymesIBA 09/2009
1	PlatinumIBA 09/2009
1	Insulin-Like Growth Factor Binding ProteinsIBA 07/2007
1	insulin-like growth factor binding protein-related protein 1IBA 07/2007
1	DNA (Deoxyribonucleic Acid)IBA 07/2007
1	Carbonic Anhydrase IXIBA 05/2004
1	Codon (Codons)IBA 04/2003
1	Proline (L-Proline)FDA Link 04/2003
1	Messenger RNA (mRNA)IBA 04/2002
1	Cyclin-Dependent Kinase Inhibitor p16IBA 04/2002

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 01/2020 - 04/2003
6	Adjuvant Chemotherapy 01/2017 - 07/2007
5	Therapeutics 01/2023 - 04/2003
5	Neoadjuvant Therapy 01/2022 - 02/2014
2	Radiotherapy 04/2004 - 04/2003
1	Treatment Delay 12/2016